# FDA 483 - Steven W. Pipe, M.D. - October 24, 2022

Source: https://www.globalkeysolutions.net/records/483/steven-w-pipe-md/6b6ace60-e276-4832-b278-a8b5cfb4bba8

> FDA 483 for Steven W. Pipe, M.D. on October 24, 2022. Product: drugs. Access full analysis and detailed observations.

---

## Details

- Record Type: 483
- Company Name: Steven W. Pipe, M.D.
- Inspection Date: 2022-10-24
- Product Type: drugs
- Office Name: Division of Pharmaceutical Quality Operations III
- Summary: An FDA inspection of Steven W. Pipe, M.D. in Ann Arbor, MI, a clinical investigator, revealed significant issues related to human subject protection and record-keeping. The firm failed to obtain proper informed consent from a human subject prior to study-related activities and did not maintain adequate case histories, including missing original consent forms and incomplete electronic correspondence.

## Related Documents

- [483 - 2012-08-17](https://www.globalkeysolutions.net/records/483/steven-w-pipe-md/9c059272-d918-4e85-a32f-a4c1f537b7fd)

## Related Officers

- [investigator](https://www.globalkeysolutions.net/people/dina-a-tallman/e9bf2b98-6697-4d7c-9052-84339536acfd)

Company: https://www.globalkeysolutions.net/companies/steven-w-pipe-md/a25c8c81-1755-457a-a62c-a015c3b487d7

Office: https://www.globalkeysolutions.net/offices/division-of-pharmaceutical-quality-operations-iii/45bc2d0d-d731-4955-aeb5-59aa0b76e4f0